Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy

BACKGROUND: To date, no systemic therapy, including immunotherapy, exists to improve clinical outcomes in metastatic uveal melanoma (UM) patients. To understand the role of immune infiltrates in the genesis, metastasis, and response to treatment for UM, we systematically characterized immune profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yong, Bollin, Kathryn, de Macedo, Mariana Petaccia, Carapeto, Fernando, Kim, Kevin B, Roszik, Jason, Wani, Khalida M, Reuben, Alexandre, Reddy, Sujan T, Williams, Michelle D, Tetzlaff, Michael T, Wang, Wei-Lien, Gombos, Dan S, Esmaeli, Bita, Lazar, Alexander J, Hwu, Patrick, Patel, Sapna P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674090/
https://www.ncbi.nlm.nih.gov/pubmed/33203661
http://dx.doi.org/10.1136/jitc-2020-000960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674090/
https://www.ncbi.nlm.nih.gov/pubmed/33203661
http://dx.doi.org/10.1136/jitc-2020-000960

Ejemplares similares